These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8121331)

  • 1. Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients.
    Kronborg G; Fomsgaard A; Høiby N
    Med Microbiol Immunol; 1993 Dec; 182(6):305-16. PubMed ID: 8121331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An easy microtiter assay for quantitation of cytokine induction by lipopolysaccharide (LPS) and activity of LPS-binding serum components.
    Garde AH; Fomsgaard A; Høiby N
    APMIS; 1995 Apr; 103(4):286-92. PubMed ID: 7612259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of oxidative burst response in human neutrophils by immune complexes made in vitro of lipopolysaccharide and hyperimmune serum from chronically infected patients.
    Kronborg G; Fomsgaard A; Jensen ET; Kharazmi A; Høiby N
    APMIS; 1993 Nov; 101(11):887-94. PubMed ID: 8286097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
    Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
    Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
    Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
    J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
    Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
    J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
    Høiby N; Hertz JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
    Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
    J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Dinesen B; Shand GH; Pressler T; Høiby N
    J Clin Microbiol; 1989 Jun; 27(6):1222-9. PubMed ID: 2502558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Fomsgaard A; Høiby N; Shand GH; Conrad RS; Galanos C
    Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies.
    Morrin M; Reen DJ
    J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.
    Pham A; Ledger EL; Coggon CF; Henderson IR; Reid DW; Bell SC; Smith DJ; Wells TJ
    Infect Immun; 2021 Nov; 89(12):e0041221. PubMed ID: 34460286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A.
    Feist W; Ulmer AJ; Wang MH; Musehold J; Schlüter C; Gerdes J; Herzbeck H; Brade H; Kusumoto S; Diamantstein T
    FEMS Microbiol Immunol; 1992 Jan; 4(2):73-89. PubMed ID: 1547025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
    Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
    Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.